| __timestamp | Soleno Therapeutics, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 47795223 |
| Thursday, January 1, 2015 | 4536244 | 50426000 |
| Friday, January 1, 2016 | 5184803 | 70853000 |
| Sunday, January 1, 2017 | 3068742 | 78168000 |
| Monday, January 1, 2018 | 7178000 | 123757000 |
| Tuesday, January 1, 2019 | 16267000 | 140963000 |
| Wednesday, January 1, 2020 | 23191000 | 131773000 |
| Friday, January 1, 2021 | 21453000 | 210328000 |
| Saturday, January 1, 2022 | 15265000 | 235780000 |
| Sunday, January 1, 2023 | 25189000 | 244990000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Soleno Therapeutics, Inc. and Travere Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Travere Therapeutics consistently outpaced Soleno in R&D spending, with a peak in 2023 where Travere's expenses were nearly ten times higher than Soleno's. This trend underscores Travere's aggressive pursuit of new therapies, particularly in the latter half of the decade. Meanwhile, Soleno's R&D expenses showed a steady increase, culminating in a significant 11% rise from 2022 to 2023.
These financial commitments reflect each company's strategic priorities and potential for future breakthroughs, offering investors and stakeholders a glimpse into their innovative futures.
R&D Insights: How Novartis AG and Soleno Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Novartis AG vs Travere Therapeutics, Inc.
Amgen Inc. or Travere Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Soleno Therapeutics, Inc.
Exelixis, Inc. or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
R&D Insights: How Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Soleno Therapeutics, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Travere Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and Travere Therapeutics, Inc.